Association between polymorphism in intron 1 of cocaine- and amphetamine-regulated transcript gene with alcoholism, but not with bipolar disorder and schizophrenia in Korean population

Neuroscience Letters
Sung Koo JungSung-Vin Yim

Abstract

Cocaine- and amphetamine-regulated transcript (CART) peptide is a novel neuropeptide involved in feeding, drug reward, and stress. We hypothesized that the polymorphism of CART gene might be related with susceptibility to neuropsychiatric diseases such as alcoholism, bipolar disorder, and schizophrenia. The polymorphism (rs2239670) in intron 1 was selected for study among other single nucleotide polymorphisms (SNPs) located at the area of CART gene, because it had not been tested until to date. The study included patients of alcoholism (100), bipolar disorder (76) and schizophrenia (169) from the Korean population. Healthy controls for bipolar disorder and schizophrenia consisted of 333 individuals. For alcoholism, both patient group and control subjects included only male. The restriction fragment length polymorphism (RFLP) using the AvaII restriction enzyme was designed to analyze the selected SNP. The distribution of GG, GA, and AA genotypes in the 333 controls was 50.2, 41.1, and 8.7%, respectively. The frequency of G and A alleles in the 333 controls was 70.7 and 29.3%, respectively. The distribution of genotype and allele frequencies of the AvaII polymorphism showed a significant difference between alcoholism and controls...Continue Reading

References

Jan 1, 1995·Psychiatric Genetics·T SanderL G Schmidt
Jul 22, 1998·Archives of General Psychiatry·D A NielsenM Linnoila
Jan 30, 1999·The International Journal of Biochemistry & Cell Biology·L ThimB S Wulff
Dec 29, 1999·Brain Research·L D AdamsM J Kuhar
May 11, 2000·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·K WalderE Ravussin
Jan 16, 2002·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·K YamadaZ Makita
Jul 31, 2002·Neuropeptides·M J KuharB Balkan

❮ Previous
Next ❯

Citations

Apr 18, 2008·The Cerebellum·S Hossein FatemiRobert W Sidwell
Sep 20, 2008·Nature Reviews. Neuroscience·G RoggeM J Kuhar
Jan 13, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·S Hossein FatemiMitsunori Fukuda
Jul 20, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Manoj P DandekarNishikant K Subhedar
Jan 29, 2014·Peptides·Nishikant K SubhedarDadasaheb M Kokare
Jan 27, 2016·The American Journal of Drug and Alcohol Abuse·Heather XiaoE Sherwood Brown
Apr 7, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Amaya BustoJames L Kennedy
Oct 21, 2015·Genes, Brain, and Behavior·K MarballiI Ponomarev
Jul 23, 2008·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·Yasuhiro KobayashiGeoffrey C Waldbieser
Dec 22, 2007·Psychiatry Research·Lena BrundinAsa Petersén
Feb 3, 2009·Alcoholism, Clinical and Experimental Research·Narelle K HansellNicholas G Martin
Jun 13, 2006·Peptides·Jason N Jaworski, Douglas C Jones
Jul 15, 2006·The Journal of Pharmacology and Experimental Therapeutics·Aleksandra Vicentic, Douglas C Jones
Apr 15, 2015·Menopause : the Journal of the North American Menopause Society·Eun Hee ChunJung Gu Kim
Apr 27, 2020·Brain Research·Zhi Yi Ong, Gavan P McNally

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.